Matches in SemOpenAlex for { <https://semopenalex.org/work/W3032960251> ?p ?o ?g. }
- W3032960251 endingPage "255" @default.
- W3032960251 startingPage "242" @default.
- W3032960251 abstract "Intestinal fibrosis is the final pathological outcome of chronic intestinal inflammation without specific therapeutic drugs, which leads to ileus and surgical intervention. Intestinal fibrosis is characterized by excessive deposition of extracellular matrix (ECM). The role of mast cells (MCs), which are members of the sentinel immune cell population, is unknown in intestinal fibrosis.In this study, we analyzed changes in MCs, tryptase proteins, and ECM components in human fibrotic and control patient intestines. We constructed dextran sodium sulfate-induced intestinal fibrosis models using wild-type mice, MC-reconstituted mice, and MC-deficient mice to explore the role of MCs and tryptase in intestinal fibrosis. The roles and mechanisms of MCs and tryptase on fibroblasts were evaluated using human MCs (HMC-1 and LAD-2), commercial tryptase proteins, human colon fibroblasts (CCD-18Co fibroblasts), the tryptase inhibitor APC366, and the protease-activated receptor-2 (PAR-2) antagonist ENMD-1068.Regardless of whether the colon was a human colon or a mouse colon, the fibrotic intestinal tissue had increased MC infiltration and a higher expression of ECM proteins or genes than that of the control group. The dextran sodium sulfate-induced intestinal fibrosis in MC-deficient mice was alleviated compared with that in wild-type mice. After MC reconstruction in MC-deficient mice, the alleviating effect disappeared. Tryptase, as a content stored in MC granules, was released into fibrotic intestinal tissues in the form of degranulation, resulting in an increased expression of tryptase. Compared with the control group, the tryptase inhibition group (the APC366 group) had reduced intestinal fibrosis. The CCD-18Co fibroblasts, when cocultured with MCs or treated with tryptase proteins, were activated to differentiate into myofibroblasts and secrete more ECM proteins (such as collagen and fibronectin). The underlying mechanism of fibroblast activation by tryptase was the activation of the PAR-2/Akt/mTOR pathway.We found that MC tryptase promotes inflammatory bowel disease-induced intestinal fibrosis. The underlying mechanism is that tryptase promotes the differentiation of fibroblasts into fibrotic-phenotype myofibroblasts by activating the PAR-2/Akt/ mTOR pathway of fibroblasts." @default.
- W3032960251 created "2020-06-12" @default.
- W3032960251 creator A5011812395 @default.
- W3032960251 creator A5020631185 @default.
- W3032960251 creator A5023392322 @default.
- W3032960251 creator A5034807372 @default.
- W3032960251 creator A5040205022 @default.
- W3032960251 creator A5057418739 @default.
- W3032960251 creator A5074243377 @default.
- W3032960251 creator A5080390424 @default.
- W3032960251 creator A5081892881 @default.
- W3032960251 creator A5091122364 @default.
- W3032960251 date "2020-06-08" @default.
- W3032960251 modified "2023-10-16" @default.
- W3032960251 title "Mast Cell Tryptase Promotes Inflammatory Bowel Disease–Induced Intestinal Fibrosis" @default.
- W3032960251 cites W1505584712 @default.
- W3032960251 cites W1966642918 @default.
- W3032960251 cites W1988156447 @default.
- W3032960251 cites W1994793711 @default.
- W3032960251 cites W1995528629 @default.
- W3032960251 cites W1997413662 @default.
- W3032960251 cites W2012568931 @default.
- W3032960251 cites W2013537969 @default.
- W3032960251 cites W2017946623 @default.
- W3032960251 cites W2019851250 @default.
- W3032960251 cites W2020639809 @default.
- W3032960251 cites W2033982645 @default.
- W3032960251 cites W2043000199 @default.
- W3032960251 cites W2043992563 @default.
- W3032960251 cites W2051696368 @default.
- W3032960251 cites W2055644324 @default.
- W3032960251 cites W2056771634 @default.
- W3032960251 cites W2061942376 @default.
- W3032960251 cites W2062023768 @default.
- W3032960251 cites W2062809449 @default.
- W3032960251 cites W2087795802 @default.
- W3032960251 cites W2093260288 @default.
- W3032960251 cites W2107217007 @default.
- W3032960251 cites W2113907161 @default.
- W3032960251 cites W2115865518 @default.
- W3032960251 cites W2122776035 @default.
- W3032960251 cites W2128390516 @default.
- W3032960251 cites W2147489302 @default.
- W3032960251 cites W2147639753 @default.
- W3032960251 cites W2149705807 @default.
- W3032960251 cites W2158050885 @default.
- W3032960251 cites W2160475635 @default.
- W3032960251 cites W2160638553 @default.
- W3032960251 cites W2160698607 @default.
- W3032960251 cites W2160911117 @default.
- W3032960251 cites W2161222128 @default.
- W3032960251 cites W2165928553 @default.
- W3032960251 cites W2169711167 @default.
- W3032960251 cites W2181662501 @default.
- W3032960251 cites W2196230097 @default.
- W3032960251 cites W2312233923 @default.
- W3032960251 cites W2346861401 @default.
- W3032960251 cites W2586439973 @default.
- W3032960251 cites W2623667099 @default.
- W3032960251 cites W2694013831 @default.
- W3032960251 cites W2734709214 @default.
- W3032960251 cites W2753275287 @default.
- W3032960251 cites W2791981320 @default.
- W3032960251 cites W2794231249 @default.
- W3032960251 cites W2799753475 @default.
- W3032960251 cites W2801430251 @default.
- W3032960251 cites W2803128632 @default.
- W3032960251 cites W2890793600 @default.
- W3032960251 cites W2896567413 @default.
- W3032960251 cites W2897474180 @default.
- W3032960251 cites W2898064289 @default.
- W3032960251 cites W2903110774 @default.
- W3032960251 cites W2906182962 @default.
- W3032960251 cites W2916127417 @default.
- W3032960251 cites W2947024711 @default.
- W3032960251 doi "https://doi.org/10.1093/ibd/izaa125" @default.
- W3032960251 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32507895" @default.
- W3032960251 hasPublicationYear "2020" @default.
- W3032960251 type Work @default.
- W3032960251 sameAs 3032960251 @default.
- W3032960251 citedByCount "21" @default.
- W3032960251 countsByYear W30329602512021 @default.
- W3032960251 countsByYear W30329602512022 @default.
- W3032960251 countsByYear W30329602512023 @default.
- W3032960251 crossrefType "journal-article" @default.
- W3032960251 hasAuthorship W3032960251A5011812395 @default.
- W3032960251 hasAuthorship W3032960251A5020631185 @default.
- W3032960251 hasAuthorship W3032960251A5023392322 @default.
- W3032960251 hasAuthorship W3032960251A5034807372 @default.
- W3032960251 hasAuthorship W3032960251A5040205022 @default.
- W3032960251 hasAuthorship W3032960251A5057418739 @default.
- W3032960251 hasAuthorship W3032960251A5074243377 @default.
- W3032960251 hasAuthorship W3032960251A5080390424 @default.
- W3032960251 hasAuthorship W3032960251A5081892881 @default.
- W3032960251 hasAuthorship W3032960251A5091122364 @default.
- W3032960251 hasConcept C126322002 @default.
- W3032960251 hasConcept C142724271 @default.
- W3032960251 hasConcept C170493617 @default.